证券代码：002570 证券简称：贝因美 公告编号：2025-076 贝因美股份有限公司 关于公司重大诉讼事项的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示： 1、案件所处的诉讼阶段：浙江省杭州市中级人民法院已经受理，尚未开庭 审理。 2、公司所处的当事人地位：原告。 3、涉案金额：本诉请求金额为 56,852,397.26 元（其中，利息损失暂算至 2025 年 11 月 20 日）。 原告：贝因美股份有限公司 被告：黑龙江丰佑麻类种植有限公司 2、案件事实和理由 公司与黑龙江丰佑于 2021 年 11 月、2022 年 1 月分别签订了《专利产品独 家许可（排他性经营）暨共同研发合作协议》《专利产品独家许可（排他性经营） 暨共同研发合作协议之补充协议》，协议约定贝因美向黑龙江丰佑申请使用其所 有或拥有开发权限的专利产品，黑龙江丰佑为贝因美商业化生产提供必要的技术 支持等。合同签署后，公司于 2021 年 11 月向黑龙江丰佑支付专利许可费定金 50,000,000 元人民币，按约履行了合同义务。但是，黑龙江丰佑未就专利实施许 可事项出具授 ...

Core Viewpoint - Beiyinmei's stock has shown significant fluctuations, with a year-to-date increase of 47.98% and recent trading activity indicating a mix of buying and selling pressure [1][2]. Group 1: Stock Performance - As of December 4, Beiyinmei's stock price rose by 2.13% to 6.23 CNY per share, with a trading volume of 1.06 billion CNY and a market capitalization of 6.729 billion CNY [1]. - The stock has experienced a 2.64% increase over the last five trading days, a 2.35% decrease over the last 20 days, and a 6.74% decrease over the last 60 days [1]. - Beiyinmei has appeared on the trading leaderboard 24 times this year, with the most recent appearance on August 7, where it recorded a net buy of 17.77 million CNY [1]. Group 2: Financial Performance - For the period from January to September 2025, Beiyinmei reported a revenue of 2.033 billion CNY, a year-on-year decrease of 2.59%, while the net profit attributable to shareholders increased by 48.07% to 106 million CNY [2]. - The company has distributed a total of 9.61 billion CNY in dividends since its A-share listing, with no dividends paid in the last three years [3]. Group 3: Shareholder Information - As of September 30, 2025, Beiyinmei had 147,900 shareholders, an increase of 3.24% from the previous period, with an average of 7,302 shares held per shareholder, a decrease of 3.14% [2]. - The top ten circulating shareholders include Hong Kong Central Clearing Limited, which holds 9.1823 million shares, an increase of 4.3616 million shares from the previous period [3].

Core Viewpoint - The company, Beiningmei Co., Ltd., has initiated a share repurchase plan to enhance employee incentives and shareholder value, with a total repurchase amount not exceeding RMB 300 million and a minimum of RMB 150 million [1] Group 1: Share Repurchase Plan - The company plans to repurchase A-shares through centralized bidding, with a maximum repurchase price of RMB 9.06 per share, estimating to buy back approximately 33.11 million shares, which is about 3.07% of the total share capital [1] - As of November 30, 2025, the company has repurchased a total of 13,719,254 shares, representing 1.2703% of the total share capital, with a total transaction amount of RMB 87,254,779.92, excluding transaction fees [2] Group 2: Compliance and Regulations - The implementation of the share repurchase aligns with the company's repurchase plan and complies with relevant laws and regulations [3] - The timing, pricing, and trading methods of the share repurchase adhere to the regulations set forth by the Shenzhen Stock Exchange and the China Securities Regulatory Commission [4]

Group 1 - The company Beiningmei (SZ 002570) announced on December 1 that it has repurchased approximately 13.72 million shares, accounting for 1.2703% of its total share capital, with a total transaction amount of about 87.25 million yuan [1] - The highest transaction price for the repurchased shares was 7.21 yuan per share, while the lowest was 6.01 yuan per share [1] - As of the announcement, Beiningmei's market capitalization stands at 6.8 billion yuan [1] Group 2 - For the year 2024, Beiningmei's revenue composition is entirely from the infant and child industry, with a 100.0% share [1]

格隆汇12月1日丨贝因美（维权）(002570.SZ)公布，截至2025年11月30日，公司通过股份回购专用证券 账户以集中竞价交易方式累计回购公司股份13,719,254股，占公司总股本的1.2703%，最高成交价为7.21 元/股，最低成交价为6.01元/股，成交总金额为87,254,779.92元（不含交易费用）。 ...

证券代码：002570 证券简称：贝因美 公告编号：2025-075 贝因美股份有限公司 关于回购公司股份的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 贝因美股份有限公司（以下简称"公司"）于 2025 年 4 月 29 日召开的第九 届董事会第九次会议审议通过了《关于回购公司股份方案的议案》，公司拟以集 中竞价交易方式回购公司 A 股股票，用于公司未来实施的股权激励或员工持股 计划。本次回购金额不超过人民币 3 亿元（含），不低于人民币 1.5 亿元（含）， 回购价格不超过 9.06 元/股（含）。根据最高回购规模、回购价格上限测算，预 计回购股份数量为 3,311.26 万股，约占公司目前总股本的 3.07%。具体内容详见 公 司 于 2025 年 4 月 30 日 披 露 于 指 定 信 息 披 露 媒 体 及 巨 潮 资 讯 网 （http://www.cninfo.com.cn）上的《关于回购公司股份方案暨取得股票回购专项 贷款承诺函的公告》（公告编号：2025-035）。 根据《上市公司股份回购规则》《深圳证券交易所上市公司自律监管指 ...

Core Viewpoint - Beiyinmei's innovative product "Red Love 666" calcium vitamin D3 complex energy drink has achieved significant market recognition, ranking among the top three in the infant and child nutrition product category on Douyin's 2025 Double 11 sales list [1][4]. Group 1: Product Performance - The "Red Love 666" liquid calcium product not only leads in sales but has also received endorsements from several authoritative media and top evaluation institutions, marking a key step in Beiyinmei's strategic transformation from infant formula to comprehensive nutrition products [2][8]. - During the Double 11 sales event, the product showcased strong market appeal, with significant sales achieved through live streaming by key influencers, surpassing 10 million yuan in sales [8][9]. Group 2: Nutritional Insights - Calcium is an essential element for human health, crucial for maintaining bone health and supporting normal growth and development. The recommended daily calcium intake varies by age, with children aged 1-4 needing 500 mg and adults requiring between 800-2000 mg [5][6]. - Despite the ongoing calcium supplementation trend, data indicates a severe deficiency in calcium among the population, with an average intake of only 400 mg per day [6]. Group 3: Innovation and Research - Beiyinmei's "Red Love 666" liquid calcium product is based on 33 years of life nutrition science research, addressing modern children's complex nutritional challenges through a comprehensive nutrient system that enhances calcium absorption and deposition in bones [7][10]. - The company has a robust research foundation, with over 6,000 square meters of independent R&D space, 13 research centers, and a national postdoctoral research station, leveraging extensive data on Chinese breast milk to support product innovation [14][15]. Group 4: Strategic Transformation - The launch of the "Red Love 666" product is seen as a pivotal move in Beiyinmei's strategy to transition from a focus on infant formula to a broader range of family nutrition products, creating new growth opportunities in the market [15][18]. - Beiyinmei is adapting to market changes by exploring a second growth curve centered around family needs, expanding its product offerings to include adult nutrition, diapers, and other health-related products [15][17]. Group 5: Future Outlook - Beiyinmei aims to uphold its commitment to quality and continue tapping into the health consumption potential of Chinese families, providing scientific, safe, and effective nutrition solutions tailored to various life stages and scenarios [19].

Market Overview - The beverage and dairy sector increased by 1.88% on November 28, with Yantang Dairy leading the gains [1] - The Shanghai Composite Index closed at 3888.6, up 0.34%, while the Shenzhen Component Index closed at 12984.08, up 0.85% [1] Stock Performance - Notable stock performances include: - Caobo Dao V (002732) rose by 9.99% to a closing price of 20.03, with a trading volume of 163,400 shares and a turnover of 322 million yuan [1] - Sunshine Dairy (001318) also increased by 9.99% to 15.97, with a trading volume of 126,000 shares and a turnover of 198 million yuan [1] - Panda Dairy (300898) saw a 5.90% increase, closing at 29.42 with a trading volume of 151,100 shares and a turnover of 441 million yuan [1] Capital Flow - The beverage and dairy sector experienced a net inflow of 433 million yuan from institutional investors, while retail investors saw a net outflow of 284 million yuan [2] - Key stocks in terms of capital flow include: - Yili Group (600887) had a net inflow of 117 million yuan from institutional investors, but a net outflow of 130 million yuan from retail investors [3] - Sunshine Dairy (001318) had a net inflow of 91 million yuan from institutional investors, with significant outflows from both retail and speculative investors [3]

Core Viewpoint - Beiyinmei's stock price has shown significant fluctuations, with a year-to-date increase of 47.51%, despite recent declines in the last 20 and 60 days [1][2]. Group 1: Stock Performance - As of November 28, Beiyinmei's stock price rose by 2.31% to 6.21 CNY per share, with a total market capitalization of 6.707 billion CNY [1]. - The stock has experienced a trading volume of 99.907 million CNY, with a turnover rate of 1.50% [1]. - Year-to-date, Beiyinmei's stock has been on the龙虎榜 (top trading list) 24 times, with the most recent appearance on August 7, where it recorded a net buy of 17.7676 million CNY [1]. Group 2: Financial Performance - For the period from January to September 2025, Beiyinmei reported a revenue of 2.033 billion CNY, a year-on-year decrease of 2.59%, while the net profit attributable to shareholders increased by 48.07% to 106 million CNY [2]. - The company's main revenue sources include milk powder (89.20%), with other categories contributing significantly less [1]. Group 3: Shareholder Information - As of September 30, 2025, Beiyinmei had 147,900 shareholders, an increase of 3.24% from the previous period, with an average of 7,302 circulating shares per shareholder, a decrease of 3.14% [2]. - The company has distributed a total of 9.61 billion CNY in dividends since its A-share listing, with no dividends paid in the last three years [3].

Core Viewpoint - The company announced a share buyback program, indicating confidence in its financial health and future prospects [2] Summary by Categories Company Actions - As of November 20, 2025, the company has repurchased a total of 11,738,254 shares through a dedicated securities account via centralized bidding, which represents 1.0868% of the company's total share capital [2]